[5 min read] Inflamed seborrheic keratosis: A great mimic of malignancy

seborrheic keratosis

Our first research commentary for 2022 is from the Australasian Journal of Dermatology, a paper from Spain, that looks at inflamed seborrheic keratoses (iSK) and how they are a great mimic of malignancy. Continue reading “[5 min read] Inflamed seborrheic keratosis: A great mimic of malignancy”

[5 min read] Impact of COVID-19 on melanoma diagnoses in Australia

covid-19

All our lives have been up-ended in so many ways by COVID-19 over these last two years. Many people have suffered significantly with regular and urgent health care delayed. Continue reading “[5 min read] Impact of COVID-19 on melanoma diagnoses in Australia”

[5 min read] Melanoma size not a reliable predictor of invasion | Prof David Wilkinson

melanoma

This month’s paper is from the SCARD database, and reports on the features of over 600 melanomas diagnosed by almost 30 GPs across Australia. Continue reading “[5 min read] Melanoma size not a reliable predictor of invasion | Prof David Wilkinson”

[5 min read] BCC & SCC treatment guidelines | Prof David Wilkinson

SCC BCC treatment

Recently I was reading through the latest treatment guidelines for basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), as produced by the British Association of Dermatologists (BAD).

Continue reading “[5 min read] BCC & SCC treatment guidelines | Prof David Wilkinson”

[10 min read] Sentinel lymph node biopsy: Where do we stand?

sentinel lymph node biopsy

This month’s research article is about sentinel lymph node biopsy (SLNB), and is in the form of a viewpoint from two clinicians at the centre of excellence that is Memorial Sloan Kettering Cancer Center in New York. Continue reading “[10 min read] Sentinel lymph node biopsy: Where do we stand?”

[Resource] Melanoma treatment guidelines 2021

melanoma guidelines

If you see patients with skin cancer concerns in your practice, it is essential that you stay up to date with the latest melanoma guidelines. This helpful guide prepared by Professor David Wilkinson – who designed and led the development of the only Master of Medicine degree in skin cancer – provides an outline for the management of melanoma in a primary care or skin cancer practice. Continue reading “[Resource] Melanoma treatment guidelines 2021”

[12 min read] The role of sentinel lymph node biopsy in melanoma management

Posted on
sentinel lymph node biopsy

What is your position regarding the role of sentinel lymph node biopsy (SLNB) in the management of patients with melanoma?

Do you know what the latest national guidelines are? Do you follow them? Continue reading “[12 min read] The role of sentinel lymph node biopsy in melanoma management”

[9 min read] Concordance between patient concerns and skin cancer diagnosis

This month’s research article caught my eye because it is such a simple, yet useful and relevant study. From a single practice in Brisbane, the paper reports on the agreement or not between lesions of concern to a patient, and those identified by the dermatologist, upon examination.  Continue reading “[9 min read] Concordance between patient concerns and skin cancer diagnosis”

[6 min watch] Skin Cancer Update with Prof Giuseppe Argenziano | April 2021

skin cancer update

In this month’s skin cancer update video with Professor Giuseppe Argenziano, we look at his latest fascinating study into how patient management can change after diagnostic review by a second dermatopathologist.  Continue reading “[6 min watch] Skin Cancer Update with Prof Giuseppe Argenziano | April 2021”

[8 min read] Detecting melanoma in high-risk patients | Prof David Wilkinson

melanoma

This month I draw your attention to what I believe is a profoundly important piece of research. The research – done in Australia – demonstrates the value of using a mixture of total body photography (TBP) and selected sequential digital dermoscopy (SDDI) among high risk patients, in terms of identifying melanoma. Continue reading “[8 min read] Detecting melanoma in high-risk patients | Prof David Wilkinson”